March 11, 2020 / 6:20 AM / 3 months ago

BRIEF-Newron Updates On STARS Study FDA Interaction

March 11 (Reuters) - Newron Pharmaceuticals SpA:

*

* NEWRON PHARMACEUTICALS SPA - RECEIVED FINAL MINUTES FROM MEETING WITH U.S. FDA HELD ON FEB. 5, 2020

* NEWRON PHARMACEUTICALS SPA - PARTIES DISCUSSED COMPANY’S STATISTICAL ANALYSIS PLAN, SUBMITTED TO FDA IN SEPT 2019, AND FDA’S RECOMMENDATIONS

* NEWRON PHARMACEUTICALS SPA - CLINICAL DATABASE FOR STARS STUDY REMAINS LOCKED AND BLINDED. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below